Omada Health (NASDAQ:OMDA) Price Target Raised to $30.00 at JPMorgan Chase & Co.

Omada Health (NASDAQ:OMDA) had its price target upped by JPMorgan Chase & Co. from $26.00 to $30.00 in a research note issued to investors on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

OMDA has been the subject of a number of other research reports. Citigroup restated an “outperform” rating on shares of Omada Health in a research note on Friday. The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Wells Fargo & Company raised their price objective on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Canaccord Genuity Group lifted their target price on Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Finally, Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Eleven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Omada Health has a consensus rating of “Moderate Buy” and a consensus target price of $26.50.

Omada Health Trading Down 1.4%

Shares of Omada Health stock opened at $24.04 on Friday. Omada Health has a 12-month low of $10.28 and a 12-month high of $26.92. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 480.80 and a beta of 1.73. The firm’s 50 day simple moving average is $20.99 and its two-hundred day simple moving average is $16.49.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.10. The business had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. On average, sell-side analysts predict that Omada Health will post -0.01 EPS for the current fiscal year.

Insider Buying and Selling at Omada Health

In other Omada Health news, President Wei-Li Shao sold 8,866 shares of the company’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $25.02, for a total value of $221,827.32. Following the sale, the president directly owned 307,372 shares of the company’s stock, valued at approximately $7,690,447.44. This represents a 2.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Craig Gracey sold 1,042 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $25.00, for a total value of $26,050.00. Following the sale, the chief accounting officer directly owned 15,441 shares in the company, valued at $386,025. This represents a 6.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 254,726 shares of company stock valued at $5,370,496 in the last three months. Company insiders own 6.38% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of OMDA. Quarry LP purchased a new stake in Omada Health in the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. acquired a new stake in shares of Omada Health during the 4th quarter worth approximately $32,000. Raymond James Financial Inc. purchased a new position in shares of Omada Health during the 2nd quarter valued at approximately $32,000. Versant Capital Management Inc lifted its stake in shares of Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares during the period. Finally, Strs Ohio boosted its holdings in Omada Health by 151.0% during the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after buying an additional 2,567 shares in the last quarter.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.